Skip to main content

Table 3 Toxicity outcomes in the mistletoe and non-mistletoe groups

From: Effect of mistletoe extract on tumor response in neoadjuvant chemoradiotherapy for rectal cancer: a cohort study

Toxicity

CTCAE

P-value¶

MG (n = 15)

NMG (n = 37)

 

Grade 1

Grade 2

Grade 3

Grade 4

Grade 1

Grade 2

Grade 3

Grade 4

Neutropenia

0

0

0

0

0

1 (2.7)

0

0

> 0.99

Anemia

0

0

0

0

0

0

1 (2.7)

0

> 0.99

Thrombocytopenia

0

0

0

0

0

0

0

0

–

Nausea

4 (26.7)

0

0

0

6 (16.2)

0

0

0

0.448

Vomiting

1 (6.7)

0

0

0

0

0

0

0

0.288

Diarrhea

2 (13.3)

0

0

0

5 (13.5)

0

0

0

> 0.99

Constipation

0

0

0

0

4 (2.8)

0

0

0

0.311

Proctitis

9 (60.0)

0

0

0

10 (27.0)

0

0

0

0.054

Oral mucositis

0

0

0

0

1 (2.7)

0

0

0

> 0.99

Peripheral neuropathy

1 (6.7)

0

0

0

0

0

0

0

0.288

Pruritus

3 (20.0)

0

0

0

0

0

0

0

0.021

  1. Data are presented as n (%)
  2. ¶Chi-square test or Fisher’s exact test
  3. CTCAE, Common Terminology Criteria for Adverse Events version 3.0; MG, mistletoe group; NMG, non-mistletoe group